Retrograde Autologous Priming for Minimally Invasive Mitral Valve Surgery.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
08 2022
Historique:
received: 13 01 2022
revised: 05 03 2022
accepted: 27 03 2022
pubmed: 27 5 2022
medline: 16 6 2022
entrez: 26 5 2022
Statut: ppublish

Résumé

Little is known about the safety and clinical utility of retrograde autologous priming (RAP) in patients undergoing minimally invasive mitral valve surgery. The study authors hypothesized that RAP would increase the oxygen delivery index (DO2i) while decreasing red blood cell transfusion requirements compared to valve surgery without RAP. The study was an observational analysis. A single institutional study. The authors analyzed data from 500 consecutive patients who underwent minimally invasive isolated mitral valve repair from December 31, 2012, to December 31, 2019. RAP was performed in 235 patients (47%) prior to the initiation of cardiopulmonary bypass (CPB). A continuous monitoring system was used for DO2 management during CPB. The mean arterial pressure was maintained between 55 and 70 mmHg, and the cardiac index was set at 2.4 L/min/m In a minimally invasive mitral valve context, RAP was safe and associated with better DO2i, higher hematocrit, and fewer intraoperative and postoperative red blood cell transfusions.

Identifiants

pubmed: 35618591
pii: S1053-0770(22)00209-9
doi: 10.1053/j.jvca.2022.03.031
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3028-3035

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest None.

Auteurs

Marco Moscarelli (M)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy. Electronic address: m.moscarelli@imperial.ac.uk.

Ignazio Condello (I)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Anna Mancini (A)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Valeria Rao (V)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Flavio Fiore (F)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Raffaele Bonifazi (R)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Nicola Di Bari (N)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Giuseppe Nasso (G)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Giuseppe Speziale (G)

Department of Cardiovascular Surgery, GVM Care and Research, Anthea Hospital, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH